. (2016). Estimating the economic burden of cardiovascular events in patients receiving lipid-modifying therapy in the UK. BMJ Open. http://doi.org/10.1136/bmjopen-2016-011805
M. Danese
First name
M.
Middle name
D.
Last name
Danese
. (2017). Methods for estimating costs in patients with hyperlipidemia experiencing their first cardiovascular event in the United Kingdom. J Med Econ. http://doi.org/10.1080/13696998.2017.1345747
. (2017). Management of lipid-lowering therapy in patients with cardiovascular events in the UK: a retrospective cohort study. BMJ Open. http://doi.org/10.1136/bmjopen-2016-013851
. (2018). The prevalence, low-density lipoprotein cholesterol levels, and treatment of patients at very high risk of cardiovascular events in the United Kingdom: a cross-sectional study. Curr Med Res Opin. http://doi.org/10.1080/03007995.2018.1463211
. (2018). Association of a Combined Measure of Adherence and Treatment Intensity With Cardiovascular Outcomes in Patients With Atherosclerosis or Other Cardiovascular Risk Factors Treated With Statins and/or Ezetimibe. JAMA Netw Open. http://doi.org/10.1001/jamanetworkopen.2018.5554
. (2019). The Generalized Data Model for clinical research. BMC Med Inform Decis Mak. http://doi.org/10.1186/s12911-019-0837-5
. (2020). Estimation of the increased risk associated with recurrent events or polyvascular atherosclerotic cardiovascular disease in the United Kingdom. Eur J Prev Cardiol. http://doi.org/10.1177/2047487319899212
. (2021). Estimation of the increased risk associated with recurrent events or polyvascular atherosclerotic cardiovascular disease in the United Kingdom. Eur J Prev Cardiol. http://doi.org/10.1177/2047487319899212